These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8178720)

  • 21. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is XELOX equivalent to FOLFOX or other continuous-infusion 5-fluorouracil chemotherapy in metastatic colorectal cancer?
    Douillard JY; Bennouna J; Senellart H
    Clin Colorectal Cancer; 2008 May; 7(3):206-11. PubMed ID: 18621641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine.
    Marshall JL; Richmond E; DeLap RJ
    Clin Cancer Res; 1996 Sep; 2(9):1475-80. PubMed ID: 9816323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant chemotherapy.
    Waters JS; Cunningham D
    Lancet; 2000 Oct; 356(9237):1276. PubMed ID: 11072976
    [No Abstract]   [Full Text] [Related]  

  • 25. Medical treatment of colorectal cancer in elderly (>70 years): GISCAD experience and future perspectives. Italian Group for the Study of Digestive Tract Cancer.
    Beretta GD; Ferrari VD; Barni S; Pancera G; Labianca R
    Tumori; 2002; 88(1 Suppl 1):S109-12. PubMed ID: 11989900
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanism of action of fluoropyrimidines: relevance to the new developments in colorectal cancer chemotherapy.
    Sobrero A; Guglielmi A; Grossi F; Puglisi F; Aschele C
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):72-7. PubMed ID: 11049035
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
    Figueredo A; Fine S; Maroun J; Walker-Dilks C; Wong S
    Cancer Prev Control; 1997 Oct; 1(4):304-19. PubMed ID: 9765754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase III multicenter randomized clinical trial to evaluate the safety and efficacy of CoFactor/5-fluorouracil/bevacizumab versus leucovorin/5-fluorouracil/bevacizumab as initial treatment for metastatic colorectal carcinoma.
    Saif MW; Merritt J; Robbins J; Stewart J; Schupp J
    Clin Colorectal Cancer; 2006 Sep; 6(3):229-34. PubMed ID: 17026795
    [No Abstract]   [Full Text] [Related]  

  • 29. Trends in the management and survival of digestive tract cancers among patients aged over 80 years.
    Bouvier AM; Launoy G; Lepage C; Faivre J
    Aliment Pharmacol Ther; 2005 Aug; 22(3):233-41. PubMed ID: 16091061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Leucovorin and 5-FU for advanced gastrointestinal cancer].
    Sasaki T; Maeda Y; Kobayashi T
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):440-6. PubMed ID: 10097740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Systemic palliative chemotherapy with 5-fluorouracil and leucovorin in disseminated colorectal cancer].
    Wiboltt K; Raskov HH
    Ugeskr Laeger; 1999 Jun; 161(25):3827-32. PubMed ID: 10412300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The biochemical modulation of 5-fluorouracil by leucovorin].
    Borner M; Brunner K
    Schweiz Med Wochenschr; 1991 Aug; 121(33):1149-56. PubMed ID: 1925442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Best treatment for colorectal cancer and confirmatory trials.
    Di Costanzo F
    Ann Oncol; 1992 Mar; 3(3):245-6. PubMed ID: 1586627
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of biological response modifiers in the management of patients with colorectal cancer.
    Wagstaff J
    Eur J Cancer; 1995; 31A(7-8):1323-5. PubMed ID: 7577044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cyclic concomitant radiotherapy-chemotherapy combination. Results of a phase I-II study in cancers of the upper aero-digestive tract].
    Vannetzel JM; Juillard JC; Clin R; Colbert N; Decroix Y; Zuili H
    Presse Med; 1987 Mar; 16(9):448-9. PubMed ID: 2951721
    [No Abstract]   [Full Text] [Related]  

  • 36. Colorectal cancer immunotherapy: a treatment quantum leap.
    Beets GL
    Br J Surg; 2021 Aug; 108(8):877-878. PubMed ID: 34378019
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical studies of the modulation of Ftorafur.
    Creaven PJ; Rustum YM; Petrelli NJ; Gorbunova VA
    Adv Exp Med Biol; 1993; 339():253-62; discussion 263. PubMed ID: 8178722
    [No Abstract]   [Full Text] [Related]  

  • 38. Ongoing clinical trials.
    Galandiuk S
    Dig Surg; 2002; 19(3):245-53. PubMed ID: 12187910
    [No Abstract]   [Full Text] [Related]  

  • 39. [Annual Congress of the American Society of Clinical Oncology, Orlando, Florida, May 2002: update on breast and digestive cancer].
    Mabro M
    Rev Med Interne; 2002 Dec; 23(12):957-9. PubMed ID: 12568103
    [No Abstract]   [Full Text] [Related]  

  • 40. Ongoing clinical trials.
    Dig Surg; 2002; 19(5):434-47. PubMed ID: 12512514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.